Ticker
CRBUCompany Name
CARIBOU BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -164.27M | -2427.19% | $ 6.77M |
3/31/2025 | $ -147.87M | -1954.67% | $ 7.57M |
12/31/2024 | $ -149.11M | -1492.04% | $ 9.99M |
9/30/2024 | $ -147.93M | -1289.12% | $ 11.47M |
6/30/2024 | $ -123.25M | -372.2% | $ 33.11M |
3/31/2024 | $ -115.07M | -344.47% | $ 33.4M |
12/31/2023 | $ -101.88M | -295.49% | $ 34.48M |
9/30/2023 | $ -94.48M | -272.99% | $ 34.61M |
6/30/2023 | $ -111.13M | -779.74% | $ 14.25M |
3/31/2023 | $ -108.31M | -737.33% | $ 14.69M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for CARIBOU BIOSCIENCES INC is calculated as follows: EBIT [ $ -36.11M ] / Revenues [ $ 12.36M ]
(=) EBIT % [ -292.1% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |